{"title":"Trends in Cannabis-related Hospitalizations in Arizona from 2016-2021 and Associations with Mental Health-related Hospitalizations.","authors":"Madeline H Meier, Haley M Hummel, Matt L Miller","doi":"10.15288/jsad.23-00379","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To examine trends in cannabis-related hospital visits in Arizona from 2016-2021 and associations with hospital visits for a mental health condition.</p><p><strong>Methods: </strong>Data were emergency department and inpatient hospital discharge records from all Arizona licensed hospitals from 2016-2021. Records comprised 18,758,614 hospital visits. Cannabis-related visits were defined by International Classification of Diseases (ICD) diagnostic code for cannabis use (unspecified use, abuse, dependence) or poisoning. Mental health visits were defined by ICD diagnostic codes for mental health conditions.</p><p><strong>Results: </strong>The rate of cannabis-related hospital visits increased from 1,301.50 per 100k visits in 2016 to 1,565.54 per 100k visits in 2021 - a 20% increase. The increase was larger for visits by adolescents and older adults ages 65+ -- 63.94% and 84.45%, respectively. Cannabis-related visits were 7.75 (95% CI: 7.69, 7.81) times as likely as visits unrelated to cannabis to have a mental health condition as the primary diagnosis from 2016-2021, and were 2.32 (95% CI: 2.30, 2.34) times as likely after adjustment for covariates, including alcohol and other substance-related diagnoses. The association between cannabis-related visits and mental health-related visits increased each year, particularly for older adults ages 65+.</p><p><strong>Conclusions: </strong>The rate of cannabis-related hospital visits is increasing, as is the cannabis-related risk of a hospital visit for a mental health condition. The increases are especially pronounced among hospital visits by older adults (ages 65+), highlighting the need for prevention and intervention in this under-recognized at-risk group.</p>","PeriodicalId":17159,"journal":{"name":"Journal of studies on alcohol and drugs","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of studies on alcohol and drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15288/jsad.23-00379","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To examine trends in cannabis-related hospital visits in Arizona from 2016-2021 and associations with hospital visits for a mental health condition.
Methods: Data were emergency department and inpatient hospital discharge records from all Arizona licensed hospitals from 2016-2021. Records comprised 18,758,614 hospital visits. Cannabis-related visits were defined by International Classification of Diseases (ICD) diagnostic code for cannabis use (unspecified use, abuse, dependence) or poisoning. Mental health visits were defined by ICD diagnostic codes for mental health conditions.
Results: The rate of cannabis-related hospital visits increased from 1,301.50 per 100k visits in 2016 to 1,565.54 per 100k visits in 2021 - a 20% increase. The increase was larger for visits by adolescents and older adults ages 65+ -- 63.94% and 84.45%, respectively. Cannabis-related visits were 7.75 (95% CI: 7.69, 7.81) times as likely as visits unrelated to cannabis to have a mental health condition as the primary diagnosis from 2016-2021, and were 2.32 (95% CI: 2.30, 2.34) times as likely after adjustment for covariates, including alcohol and other substance-related diagnoses. The association between cannabis-related visits and mental health-related visits increased each year, particularly for older adults ages 65+.
Conclusions: The rate of cannabis-related hospital visits is increasing, as is the cannabis-related risk of a hospital visit for a mental health condition. The increases are especially pronounced among hospital visits by older adults (ages 65+), highlighting the need for prevention and intervention in this under-recognized at-risk group.
期刊介绍：
The Journal of Studies on Alcohol and Drugs began in 1940 as the Quarterly Journal of Studies on Alcohol. It was founded by Howard W. Haggard, M.D., director of Yale University’s Laboratory of Applied Physiology. Dr. Haggard was a physiologist studying the effects of alcohol on the body, and he started the Journal as a way to publish the increasing amount of research on alcohol use, abuse, and treatment that emerged from Yale and other institutions in the years following the repeal of Prohibition in 1933. In addition to original research, the Journal also published abstracts summarizing other published documents dealing with alcohol. At Yale, Dr. Haggard built a large team of alcohol researchers within the Laboratory of Applied Physiology—including E.M. Jellinek, who became managing editor of the Journal in 1941. In 1943, to bring together the various alcohol research projects conducted by the Laboratory, Dr. Haggard formed the Section of Studies on Alcohol, which also became home to the Journal and its editorial staff. In 1950, the Section was renamed the Center of Alcohol Studies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
